Skip to main content
See every side of every news story
Published loading...Updated

Retro Wants to Reverse Aging – and Be Bigger than Eli Lilly and Novo Nordisk

The goal of Retro Biosciences – a biotechnology startup that has Sam Altman as its main financier – is to reverse the natural aging process and expand human life in ten years. California's company plans to combine several scientific methods – including changing the epigenetic editing mechanism (which activates and disables genes) and replacing old or sick cells with other leafy novelties – to make the body produce healthier cells within the dete…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

The goal of Retro Biosciences – a biotechnology startup that has Sam Altman as its main financier – is to reverse the natural aging process and expand human life in ten years. California's company plans to combine several scientific methods – including changing the epigenetic editing mechanism (which activates and disables genes) and replacing old or sick cells with other leafy novelties – to make the body produce healthier cells within the dete…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

braziljournal.com broke the news on Monday, May 25, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal